Literature DB >> 15769930

Feasibility of 1 hour infliximab infusions.

R F van Vollenhoven, E Gullström, L Klareskog.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15769930      PMCID： PMC1755460          DOI： 10.1136/ard.2003.017590

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Frequency of Severe Infusion Reactions Associated With Outpatient Infusion of Infliximab Without Premedications.

Authors:  Stephanie Q Hutsell; May Wu; K T Park
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

2.  The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.

Authors:  Taha Qazi; Bhavesh Shah; Mohammed El-Dib; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2015-10-06       Impact factor: 3.199

3.  Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study.

Authors:  Anna Viola; Giuseppe Costantino; Antonino Carlo Privitera; Fabrizio Bossa; Angelo Lauria; Laurino Grossi; Maria Beatrice Principi; Nicola Della Valle; Maria Cappello
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.